MADRIGAL PHARMACEUTICALS, INC. Stock Agreements
15 Contracts & Agreements
- Form of Restricted Stock Unit Agreement under Amended 2015 Stock Plan (Filed With SEC on February 23, 2023)
- Form of Nonqualified Stock Option Agreement for Directors under Amended 2015 Stock Plan (Filed With SEC on August 6, 2020)
- MADRIGAL PHARMACEUTICALS, INC. AMENDED 2015 STOCK PLAN (Filed With SEC on July 22, 2016)
- SYNTA PHARMACEUTICALS CORP. Restricted Stock Unit Award Grant Notice Restricted Stock Unit Award Grant under the Companys 2015 Stock Plan (Filed With SEC on May 10, 2016)
- SYNTA PHARMACEUTICALS CORP. 2015 STOCK PLAN (Filed With SEC on June 15, 2015)
- RESTRICTED STOCK AGREEMENT SYNTA PHARMACEUTICALS CORP. (Filed With SEC on March 12, 2015)
- RESTRICTED STOCK AGREEMENT SYNTA PHARMACEUTICALS CORP. (Filed With SEC on March 12, 2015)
- RESTRICTED STOCK AGREEMENT SYNTA PHARMACEUTICALS CORP. (Filed With SEC on November 6, 2014)
- SYNTA PHARMACEUTICALS CORP. Common Stock (par value $0.0001 per share) At the Market Issuance Sales Agreement (Filed With SEC on July 18, 2014)
- SYNTA PHARMACEUTICALS CORP. Common Stock (par value $0.0001 per share) At the Market Issuance Sales Agreement (Filed With SEC on May 8, 2014)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 13, 2012)
- SYNTA PHARMACEUTICALS CORP. Common Stock (par value $0.0001 per share) At the Market Issuance Sales Agreement (Filed With SEC on May 3, 2012)
- AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 19, 2011)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on April 15, 2011)
- COMMON STOCK PURCHASE AGREEMENT Dated as of October 4, 2010 by and between SYNTA PHARMACEUTICALS CORP. and AZIMUTH OPPORTUNITY LTD. (Filed With SEC on October 5, 2010)
